The Clinical Genomics team has accomplished an impressive number of milestones in a very short time, demonstrating the scientific excellence required to earn the trust of several credentialing groups and laying the foundation for the application of the faculty’s genomic discoveries to direct patient care.
|Licenses and Accreditations||Number||Expiration Date|
|College of American Pathologists (CAP) Accreditation||CAP: 8737269; AU-ID: 1693018||June 20, 2024|
|Clinical Laboratory Improvement Amendments (CLIA) Accreditation||07D2061461||September 16, 2022|
|State of California License||CDS 00800512||December 12, 2022|
|State of Connecticut License||CL-0695||September 30, 2021|
|State of Maryland License||2389||No Expiration|
|State of Rhode Island License||LCO00986||December 30, 2023|
* CT inspections have been paused due to the COVID-19 pandemic. No updated licenses have been issued, but this license is still valid until November 2022.
JAX Clinical Genomics provides clinical laboratory services in accordance with CLIA and CAP regulatory requirements. Assay selection and interpretation is consistent with the guidelines of relevant medical professional societies, including: